EVX-101 is in development for adjunctive Serotonin Synthesis Amplification therapy in depression and obsessive-compulsive disorder (OCD) therapy when first-line serotonin reuptake inhibitor antidepressants alone are inadequate
Here's how to match your skin's needs with the right formulation
Practical Recommendations for Clinicians Given the inconclusive data on bone safety during GLP1 treatment, clinicians should: Assess fracture risk using tools like FRAX before starting therapy Order BMD tests for patients with osteoporosis risk factors Monitor for excessive or rapid weight loss that may compromise bone mass Promote calcium and vitamin D intake, resistance training, and fall prevention strategies Refer to endocrinologists or bone specialists as needed for complex cases Future Research Questions Several questions remain unanswered about how GLP1 medications influence longterm bone integrity: Do individual GLP1 agents differ in their effects on bone remodeling
Scientists have developed several analogs of GLP-1, with the two most notable ones being semaglutide and liraglutide, which share 94-97% homology with the active form of the GLP-1 hormone [8, 9]
1 However, experience and clinical evidence consistently show that these medications are not magic bullets
There is evidence that this drug helps people lose weight quickly and easily